Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Lexicon Pharma to cut 45 pct of workforce, CEO to leave
Reuters
Monday, January 13, 2014 - 10:50am
tags:
Lexicon Pharmaceuticals, layoffs, Pharma CEOs, Arthur Sands
What Biotech Pros Will Be Chirping About at JP Morgan This Week
Xconomy
Monday, January 13, 2014 - 10:47am
tags:
JPMHC 2014, biotech, renal denervation, Intercept Pharma, Neurocrine, Illumina, Ion Torrent, Medtronic, innovation
Jazz could pay Aerial BioPharma more than $397M for narcolepsy drug in late-stage testing
Yahoo/AP
Monday, January 13, 2014 - 10:43am
tags:
Jazz Pharmaceuticals, M&A, Aerial BioPharma, narcolepsy, ADX-N05
The J.P. Morgan Healthcare Confab Monday Morning News Dump
TheStreet.com
Monday, January 13, 2014 - 10:12am
tags:
JPMHC 2014, GSK, Intercept Pharma, Acorda Therapeutics, Cell Therapeutics, Novartis, Sanofi, Alnylam, Idenix, Alexion, Galena Biopharma, Incyte, Clovis Oncology, Dendreon, Merck, Arena Pharmaceuticals
Lion Biotech: Tumor Infiltrating Lymphocyte Therapy Could Be Paradigm Shift For Treatment Of Melanoma And Other Solid Tumors
Seeking Alpha
Monday, January 13, 2014 - 10:08am
tags:
Lion Biotechnologies, cancer, adoptive cell therapy
Clovis Oncology, seen as 'next ICPT,' jumps 5%
Marketwatch
Monday, January 13, 2014 - 10:03am
tags:
Clovis Oncology
FDA Accepts New Drug Application for Gilead’s Idelalisib for the Treatment of Refractory Indolent Non-Hodgkin’s Lymphoma
Yahoo
Monday, January 13, 2014 - 9:41am
tags:
FDA, Gilead Sciences, Idelalisib, refractory indolent non-Hodgkins lymphoma
Merck says consumer or animal health move possible in 2014
Yahoo/Reuters
Monday, January 13, 2014 - 9:27am
tags:
animal health, Merck, consumer health, Novartis
Merck's anti-blood clot drug should be approved -U.S. FDA staff
Yahoo/Reuters
Monday, January 13, 2014 - 9:01am
tags:
Merck, FDA, Vorapaxar, bloodthinners
GSK hands back failed muscular dystrophy drug to Prosensa
Yahoo/Reuters
Monday, January 13, 2014 - 9:00am
tags:
GSK, Prosensa, Duchenne Muscular Dystrophy, drisapersen
St Jude says fourth-quarter earnings better than expected
Yahoo/Reuters
Monday, January 13, 2014 - 8:59am
tags:
earnings, St. Jude Medical, devices
Sanofi Pays $700 Million for Alnylam Drugs and Stake
Bloomberg
Monday, January 13, 2014 - 8:47am
tags:
Sanofi, Alnylam, Patisiran
Capricor: Can A Scarred Heart Be Repaired?
Seeking Alpha
Monday, January 13, 2014 - 8:42am
tags:
heart attacks, devices, CAP-1002, Capricor
Amarin Out, Intercept Pharma In at JPMorgan Healthcare Confab
TheStreet.com
Monday, January 13, 2014 - 8:40am
tags:
Amarin, Intercept Pharma, JPMHC 2014, OCA, Vascepa
Dr Reddy's, Zydus, Cadila seek more time for their SEZ units (in India)
Business Standard, India
Sunday, January 12, 2014 - 9:54am
tags:
Dr Reddy's, Zydus, Cadila
Pfizer Explores Use of iPad App for Early Alzheimer’s Detection
Wall St Cheat Sheet
Sunday, January 12, 2014 - 9:50am
tags:
Pfizer, Alzheimer's disease
Intercept Liver Drug Is A Game Changer For The Biotech Industry
Seeking Alpha
Sunday, January 12, 2014 - 9:47am
tags:
nonalcoholic steatohepatitis, Intercept Pharma, obeticholic acid
Revisiting My Bullish Thesis On Bristol-Myers Squib
Seeking Alpha
Sunday, January 12, 2014 - 9:19am
tags:
Bristol-Myers Squibb
The Best- And Worst-Performing Biotech Stocks,Jan. 3 to Jan. 10
Forbes
Saturday, January 11, 2014 - 10:13am
tags:
Neurocrine, Intercept Pharma, Epizyme, Sangamo BioSciences, OncoMed, Zogenix, Macrogenics, Intrexon, Pharmacyclics, Galena Biopharma
LPath Inc. A Small Biotechnology Company With Big Potential
Seeking Alpha
Saturday, January 11, 2014 - 10:10am
tags:
Lpath, iSONEP, Asonep, Lpathomab, Nextomab

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.